Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 19 Issue 8, August 2019

‘The signalling hub’, inspired by the Review on p454.

Cover design: Lara Crow.

Research Highlights

  • McAleer, Long et al. generated a reconfigurable body-on-a-chip system with recirculating medium to analyse organ function in response to anticancer drugs in real-time, which can help to improve preclinical drug testing.

    • Ulrike Harjes
    Research Highlight


  • Ligorio, Sil et al. used a combination of single-cell RNA and proteomic techniques in both model systems and human pancreatic ductal adenocarcinomas (PDACs) to better understand the interplay between cancer cells and fibroblasts, and the implications of this for PDAC progression.

    • Sarah Seton-Rogers
    Research Highlight
  • Habets, de Bock et al. show that T cell acute lymphoblastic leukaemia (T-ALL) cells only express a subclass of γ-secretase complexes. Selective inhibition of this subclass impaired NOTCH1 processing and showed therapeutic efficacy with minimal toxicity in preclinical models of T-ALL.

    • Maria Giuseppina Baratta
    Research Highlight
Top of page ⤴


  • Paediatric solid tumours are known to be divergent from adult malignancies. This Review describes the molecular landscape of paediatric solid tumours, the therapeutic vulnerabilities that can be targeted and the preclinical models available to test the efficacy of investigational drugs with a view to accelerating translational progress.

    • David T. W. Jones
    • Ana Banito
    • Stefan M. Pfister
    Review Article
  • This Review discusses the diverse effects of senescence and the senescence-associated secretory phenotype (SASP) on tumour growth, focusing on the functional and sometimes opposing outputs of the SASP in stromal cells and incipient tumour cells.

    • Douglas V. Faget
    • Qihao Ren
    • Sheila A. Stewart
    Review Article
  • The transcriptional activators YAP and TAZ have been discussed mainly for their cell-autonomous functions in cancer. Recent studies suggest their emerging roles in orchestrating tumour–stroma interactions, acting as a signalling hub, as discussed in this Review article.

    • Francesca Zanconato
    • Michelangelo Cordenonsi
    • Stefano Piccolo
    Review Article
Top of page ⤴


  • To date, very few actionable tumour-specific antigens (TSAs) have been identified that have successfully translated into therapeutic cancer vaccines. This Opinion article provides both examples of TSAs alternative to the traditional single-nucleotide variant neoantigens and details about the novel computational tools used to identify them, with the view to broaden the number of targetable antigens that can be used for cancer vaccine development.

    • Christof C. Smith
    • Sara R. Selitsky
    • Jonathan S. Serody
Top of page ⤴


Quick links